Table 1.
Characteristics of the Study Sample
| Unadjusted | Propensity Score Weighted | |||||
|---|---|---|---|---|---|---|
|
| ||||||
| Control (n=1441) |
Intervention (n=1640) |
P-Value | Control (n=1439) |
Intervention (n=1640) |
P-Value | |
|
DEMOGRAPHICS
| ||||||
| Age (Years) | 47.6 (16.3) | 49.4 (14.9) | 0.002 | 48.6 (16.9) | 48.6 (14.5) | 0.95 |
| Male | 851 (59.1%) | 861 (52.5%) | <0.001 | (55.5%) | (55.6%) | 0.96 |
| Race | 0.51 | 1.00 | ||||
| White | 879 (61.0%) | 978 (59.6%) | (60.1%) | (60.2%) | ||
| Black | 527 (36.6%) | 608 (37.1%) | (37.0%) | (36.9%) | ||
| Hispanic | 15 (1.0%) | 24 (1.5%) | (1.3%) | (1.3%) | ||
| Other | 20 (1.4%) | 30 (1.8%) | (1.6%) | (1.6%) | ||
| Insurance | 0.002 | 1.00 | ||||
| Uninsured | 399 (27.7%) | 381 (23.2%) | (25.3%) | (25.3%) | ||
| Medicare | 378 (26.2%) | 519 (31.6%) | (29.1%) | (29.1%) | ||
| Medicaid | 279 (19.4%) | 308 (18.8%) | (19.2%) | (19.0%) | ||
| Private | 337 (23.4%) | 394 (24.0%) | (23.6%) | (23.8%) | ||
| Other | 48 (3.3%) | 38 (2.3%) | (2.8%) | (2.8%) | ||
|
| ||||||
|
CLINICAL CHARACTERISTICS
| ||||||
| Charlson Score Categories | 0.001 | 0.15 | ||||
| None | 863 (59.9%) | 901 (54.9%) | (58.2%) | (56.3%) | ||
| Mild | 348 (24.1%) | 502 (30.6%) | (25.8%) | (29.3%) | ||
| Moderate | 135 (9.4%) | 142 (8.7%) | (9.5%) | (8.5%) | ||
| Severe | 95 (6.6%) | 95 (5.8%) | (6.5%) | (5.9%) | ||
| Total Comorbidities | 1.5 (1.5) | 1.6 (1.5) | 0.02 | 1.6 (1.5) | 1.6 (1.4) | 0.99 |
| Length of Stay | 5.3 (5.3) | 5.0 (4.6) | 0.09 | 5.3 (5.4) | 5.0 (4.5) | 0.17 |
Data are represented as mean (SD) for continuous variables and number (%) for categorical or only (%) for propensity score weighted categorical.